Fujifilm Diosynth Biotechnologies opens new specialist manufacturing facility in Billingham
A new specialist biotechnology manufacturing facility located in Billingham has just been officially opened, representing Fujifilm Diosynth Biotechnologies’ latest investment from a series totalling £30m over the past two years.
According to a news report on this matter, the new facility, which has been built and commissioned in less than 15 months, is the first facility of its kind in the UK, and is focused on mammalian cell culture.
Steve Bagshaw, managing director of Fujifilm Diosynth Biotechnologies UK, said: "I am delighted that we have been able to build and commission our new GMP mammalian cell culture manufacturing facility in such a short time frame.
"This new capacity, using the latest single-use technologies, provides our customers with a full life-cycle offering for mammalian cell culture biopharmaceuticals from our UK site, and complements our offering in microbial-based biologics."
Given the highly sensitive nature of the activity carried out on the premises, the implementation of a very reliable access control solution is also a very good idea, and that’s exactly where Access Control UK can put its extensive experience to very good use.
If you’d like to find out more about the range of solutions supplied by Access Control UK, both in terms of hardware (smart card readers, biometric readers, turnstiles, etc.) and software (access rights management software solutions, etc.), just contact us, we’ll be more than happy to answer any queries you might have.